Research a compound stack end to end — a structured protocol scaffold, how VialTalk researchers actually combine these compounds, receptor conflicts, and live COA-verified prices. Add 1–5 compounds.
Research signals
Redundancy, true conflicts, and dangerous additive effects
Review advised
No documented conflicts — some notes to review
Receptor activity map
| Receptor | KLOW | Glutathione | Selank | Adamax |
|---|---|---|---|---|
| GABAergic system / GABA-A receptor | ||||
| BDNF / TrkB neurotrophic axis | ||||
| Enkephalin metabolism / endogenous opioid peptide axis | ||||
| Tuftsin-origin immune / cytokine-chemokine modulation | ||||
| Glutathione peroxidase / redox buffer / Phase II detoxification axis | ||||
| ACTH 4-10 / dopaminergic neuroprotective axis | ||||
| CNTF-mimetic / LIF-signalling / BDNF transcription (P021-derived) | ||||
| Tissue-repair / angiogenic / anti-inflammatory signalling (BPC-157, TB-500, GHK-Cu, KPV) |
A structured, research-grounded protocol for this stack
Sign in to build a structured research protocol scaffold for Adamax + Selank + Glutathione + KLOW — phases, per-compound parameters, endpoints and washout, grounded in documented research.
What VialTalk researchers actually run
No researchers have logged this exact combination yet — yours could be the first.
Researchers are also adding
Best price for each compound today
Same “From” price shown on each compound's page (after discounts). Panels = COA assays tested. Tap “Compare all vendors” for the full breakdown.
For research and informational use only. VialTalk does not provide medical advice or dosing guidance. Community data reflects self-reported public research journals.